EP 1685094 A1 20060802 - ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES
Title (en)
ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES
Title (de)
MIT ACYLHARNSTOFF VERBUNDENE UND MIT SULFONYLHARNSTOFF VERBUNDENE HYDROXAMATE
Title (fr)
HYDROXAMATES CONNECTES A L'ACYLUREE ET A LA SULFONYLUREE
Publication
Application
Priority
- SG 2004000353 W 20041026
- US 51401303 P 20031027
Abstract (en)
[origin: WO2005040101A1] The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to acylurea/sulfonylurea containing compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase activities.
IPC 8 full level
C07C 275/50 (2006.01); C07C 275/54 (2006.01); C07C 311/58 (2006.01); C07C 311/60 (2006.01); C07C 335/26 (2006.01); C07D 207/27 (2006.01); C07D 209/16 (2006.01); C07D 213/40 (2006.01); C07D 233/54 (2006.01); C07D 233/61 (2006.01); C07D 235/14 (2006.01); C07D 285/06 (2006.01); C07D 295/13 (2006.01); C07D 295/215 (2006.01); C07D 307/14 (2006.01); C07D 307/85 (2006.01); C07D 333/20 (2006.01); C07D 333/38 (2006.01); C07D 207/26 (2006.01); C07D 235/10 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 1/16 (2017.12); A61P 3/00 (2017.12); A61P 3/10 (2017.12); A61P 7/00 (2017.12); A61P 7/06 (2017.12); A61P 9/00 (2017.12); A61P 9/04 (2017.12); A61P 9/08 (2017.12); A61P 9/10 (2017.12); A61P 11/06 (2017.12); A61P 13/08 (2017.12); A61P 13/10 (2017.12); A61P 17/06 (2017.12); A61P 19/02 (2017.12); A61P 21/00 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/02 (2017.12); A61P 25/08 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/18 (2017.12); A61P 25/24 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 27/06 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/10 (2017.12); A61P 31/12 (2017.12); A61P 31/22 (2017.12); A61P 33/02 (2017.12); A61P 33/06 (2017.12); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 37/02 (2017.12); A61P 37/06 (2017.12); A61P 43/00 (2017.12); C07C 275/50 (2013.01); C07C 275/54 (2013.01); C07C 311/58 (2013.01); C07C 311/60 (2013.01); C07C 335/26 (2013.01); C07D 207/27 (2013.01); C07D 209/16 (2013.01); C07D 213/40 (2013.01); C07D 233/64 (2013.01); C07D 235/14 (2013.01); C07D 285/06 (2013.01); C07D 295/13 (2013.01); C07D 295/215 (2013.01); C07D 307/14 (2013.01); C07D 307/85 (2013.01); C07D 333/20 (2013.01); C07D 333/38 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005040101 A1 20050506; AR 046920 A1 20060104; AU 2004284030 A1 20050506; CA 2543570 A1 20050506; EP 1685094 A1 20060802; EP 1685094 A4 20070822; JP 2007509930 A 20070419; MX PA06004735 A 20061214; TW 200530166 A 20050916
DOCDB simple family (application)
SG 2004000353 W 20041026; AR P040103893 A 20041026; AU 2004284030 A 20041026; CA 2543570 A 20041026; EP 04775672 A 20041026; JP 2006537946 A 20041026; MX PA06004735 A 20041026; TW 93132561 A 20041026